Latest News

• share
• favorite_border

Scientists find metabolites that were consistently linked with coronary heart disease among Black individuals.

• share
• favorite_border

In a nationwide study of Medicare beneficiaries, researchers evaluated differences in procedural care and mortality for acute cardiovascular conditions between rural and urban hospitals.

• share
• favorite_border

In a new meta-analysis of randomized, placebo-controlled COVID-19 vaccine trials, researchers compared the rates of adverse events reported by participants who received the vaccines to the rates of adverse events reported by those who received a placebo injection.

• share
• favorite_border

Physician-scientists at Beth Israel Deaconess Medical Center reported that a common type of N95 respirator reprocessed with VHP maintained its function and effectiveness through 25 cycles of re-use.

• share
• favorite_border

In a pair of papers and a guest editorial published in Dimensions of Critical Care Nursing, nurse-scientists share their experiences nearly doubling the hospital’s intensive care unit capacity; identifying, training and redeploying staff; and developing and implementing a proning team to manage patients with acute respiratory distress syndrome during the first COVID-19 surge.

• share
• favorite_border

Researchers at Beth Israel Deaconess Medical Center (BIDMC) conducted a head-to-head test of the second-generation vaccine CV2CoV compared with CVnCoV. The scientists assessed the vaccines’ ability to provoke an immune response as well as their protective efficacy against COVID-19 in non-human primates.

• share
• favorite_border

A new study suggests that because of improvements in stent technology and changes in the types of patients receiving stents, the risks of DAPT may now outweigh the benefits for the average patient.

• share
• favorite_border

In a paper published in the New England Journal of Medicine, a team of experts at Beth Israel Deaconess Medical Center compared immune responses induced by the three COVID-19 vaccines over an eight-month follow-up period.

• share
• favorite_border

Researcher-physicians at Beth Israel Deaconess Medical Center used a novel, highly-sensitive test to measure the amount of toxin produced by C. difficile in the stool of patients with suspected infections.

• share
• favorite_border

In the first randomized trial examining the role of a deep-learning based computer-aided detection system during colonoscopy in the U.S., researchers reported a relative reduction of the miss rate by nearly a third when computer-aided detection was used in conjunction with standard-of-care colonoscopy.

• share
• favorite_border

• share
• favorite_border

Researchers uncovered the precise hypothalamic neurons that regulate the drive to engage in mating behaviors in mice. The study sets the stage for developing a targeted therapy to offset the sexual side effects linked to antidepressants that can discourage patients from treating mental illnesses.

• share
• favorite_border

Researchers systematically reviewed federally funded cardiovascular disease trials run between 2000 and 2019 to determine whether various recruitment strategies impacted the number of Black participants enrolled.

• share
• favorite_border

A team led by Dan H. Barouch, MD, PhD, has been awarded $4.9 million in annual funding over the next five years to find a cure for HIV. Barouch was one of ten primary investigators to receive a 2021 National Institutes of Health (NIH) Martin Delaney Collaboratories for HIV Cure Research award, which aims to expedite human immunodeficiency virus (HIV) cure research by bringing together research partners in academia, government, the private sector and the community; coordinating complex research studies, and mentoring the next generation of HIV cure researchers.

• share
• favorite_border

Researchers conducted the largest and longest observational study to date, using multiple body weight measurements among a racially and ethnically diverse population of gender diverse individuals treated at an academic medical center and non-profit community health center in Washington, D.C. The findings suggest that transgender patients taking gender-affirming hormone therapy should be monitored for changes in body weight, body mass index and for complications that may accompany high body weight, such as cardiovascular disease.